Heart Failure

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/42

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 8:05 AM on 4/14/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

43 Terms

1
New cards

What is heart failure?

  • clinical syndrome characterised by typical symptoms:

    • SOB, ankle/body oedema and fatigue

2
New cards

What are typical symptoms of heart failure?

  • SOB, oedema and fatigue, poor exercise tolerance

3
New cards

What are signs of heart failure?

Why do these signs occur?

  • elevated jugular venous pressure, pulmonary crackles (fluid in the lungs), peripheral oedema

  • structural/functional cardiac abnormalities that result in a reduced CO

4
New cards

What does LVSD stand for?

What does this mean?

  • left ventricular systolic disease

  • left ventricle is damaged

5
New cards

What is the symptomatic heart failure ejection fraction?

  • EF <40% = symptoms e.g. SOB, oedema etc

6
New cards

What are causes of HF?

  • MI

  • hypertension

  • atrial fibrillation

  • alcohol induced cardiomyopathy

  • valve disease (HF due to valve stiffening)

  • viral infections

  • hyperthyroidism (heart beats fast, load too much = HF)

7
New cards

What recreational drug can induce HF?

  • cocaine

8
New cards

What are the aims in management of HF?

  • improve quality of life

  • reduce hospitilisation

  • prolong patient survival

9
New cards

Can you improve HF?

  • no but you can slow down the decline of patient’s health

10
New cards

When are patients with HF most often breathless?

  • at night - due to accumulation of fluid in the lungs (gravity change, when lying down)

11
New cards

What is the difference between stable oedema and decompensated odema?

  • stable = has fluid in ankle but is stable

  • decompensated = fluid building up in the lungs

12
New cards

What are examinations done to diagnose HF?

  • auscultation - sound

  • 3rd heart sound (gallop rhythm) - can indicate HF

  • jugular venous pressure

13
New cards

What are investigations done to diagnose HF?

  • chest xray - fluid in lungs

  • echo - for EF value

  • ECG - not directly to diagnose, but check for hypertension

14
New cards

What blood tests are done to diagnose HF?

  • FBC

  • U&Es

  • TFTs

  • BNP - b-type naturetic peptide

15
New cards

What do iron infusions aid with in patients with HF?

  • improves patients’ exercise tolerance regardless of whether they’re anaemic

16
New cards

What are the NYHA classifications of HF?

  • I - asymptomatic, even on exercise

  • II - HF symptoms but only on exercise

  • III - HF symptoms on very mild exercise

  • IV - HF symptoms at rest

17
New cards

What does an increase of weight >2kg in 2-3 days indicate for HF patients?

What is a self-monitoring measure patients should take?

  • indicates fluid build up

  • weighing themself and recording it to check for any sudden weight gain

18
New cards

What are dietary measures that should be recommended for patients with HF?

  • reduced sodium intake/salt substitutes (most important as Na causes fluid retention)

  • fluid restriction (1.5-2L per day - include soups, water, all fluids)

  • moderate alcohol intake

    • alcohol is a cardiotoxin

  • weight reduction if patient is obese

19
New cards

What are lifestyle changes that should be implemented in patients with HF?

  • smoking cessation

  • exercise

20
New cards

What is 1st line for treatment of HF?

Why is it given?

  • ACE-I, e.g. enalapril

  • slows down the worsening of HF

21
New cards

What are pharmacological management options for HF?

  • ACE-I (1st line)

    • enalapril, perindopril, ramipril, lisinopril, captopril, quinapril, fosinopril (all licenced for HF)

  • beta-blocker

    • only be started when patient is stable

  • aldosterone antagonist

    • where NYHA class is 3 or 4

  • sacubitril/valsartan

    • neprilysin inhibitor

    • can cause increase in bradykinin

    • must stop ACE-I for minimum 36hrs before starting

  • diuretics

    • relieves symptoms

    • non-compliance issue (increase urination)

  • digoxin

    • only if patient is v symptomatic and tried other options

    • or if patient is a fib and fluid in the lungs

  • hydralazine/isosorbide

    • not used unless renal impairment and other meds tried

  • ivabradine

22
New cards

What is entresto?

What can it cause a build up of that can result in S/E?

What must be stopped and for how long before taking entresto?

  • sacubitril and valsartan - neprilysin inhibitor and ARB

  • bradykinin

  • ACE-I must be stopped for a minimum of 36 hours before starting entresto

23
New cards

Why are diuretics used in HF patients?

What sort of diuretic is predominantly used?

  • symptom control

  • loop diuretic e.g. furosemide

24
New cards

What is an issue patients on furosemide have?

  • pee a lot so there is low compliance with the drug

25
New cards

What is an S/E of furosemide?

  • gout and increased urination

26
New cards

What should be monitored when patient is on a loop diuretic?

What dose should be given?

  • renal function and electrolytes

  • lowest effective dose

27
New cards

Are any patients w/ LVSD not to be on ACE-I?

What dose?

  • no unless there is a contraindication

  • so, regardless of age, hypotensive, patient with HF/LVSD gets put on ACE-I

  • the max dose the patient is able to tolerate

28
New cards

When on diuretics what needs to be monitored?

  • monitor renal function and electrolytes

29
New cards

What beta-blocker is cardio selective?

  • bisoprolol

30
New cards

What beta blockers are licensed for HF?

  • bisoprolol (cardioselective)

  • Carvedilol (non cardioselective)

  • Nebivolol (only if old, or can’t tolerate other 2)

31
New cards

When are aldosterone antagonists used in HF treatment?

What are examples of aldosterone antagonists?

  • in advanced HF patients (class 3-4)

  • Spironolactone and epleronone

32
New cards

When is eplerenone better to use than spironolactone?

  • if patient has S/E like gynocomastia

  • (Epleronone doesn’t cause gynocomastia while spironolactone does)

33
New cards

What are considerations when starting aldosterone antagonists in patients?

  • check serum creatinine and potassium (potassium sparing effect)

  • Careful in patient on ACE-I/ARB and a high dose diuretic (risk of hyperkalaemia)

34
New cards

What is in entresto?

  • sacubitril (neprilysin inhibitor) and valsartan (ARB)

35
New cards

What are the conditions that patients need to meet, to be considered for entresto?

  • min 1 hospitalisation in the past year

  • EF <35% (echo)

36
New cards

Who starts a patient on entresto?

  • primary care (not pharmacists)

37
New cards

When starting entresto what must be stopped and for how long?

Why does it need to be stopped?

  • stop ACE-I for minimum 36 hours

  • Need to ensure ACE-I is washed out of system, otherwise risk of angioedema developing

38
New cards

Are SGLT-2 inhibitors used in HF patients?

  • yes, even if they aren’t diabetic

  • Used as a diuretic

39
New cards

What are counselling points for SGLT-2 inhibitors?

  • increased urination, risk of UTI, bp drop

40
New cards

When is ivabradine used for HF patients?

  • if patient intolerant to beta-blocker or in addition to beta-blockers if HR >75bpm

41
New cards

What does the dose of digoxin depend on?

  • depends on renal function

42
New cards

What is the relationship between potassium levels and digoxin?

  • hypokalaemia can increase risk of digoxin toxicity

43
New cards

What drugs exacerbate HF?

  • NSAIDs and COX-2 inhibitors

  • Rate limiting CCB (slows HR down too much)

  • Chemotherapy drugs

  • Cough/cold medicines e.g. oxymetazoline

  • Anti-psychotics e.g. clozapine

  • Glitazones

  • Corticosteroids and other fluid-retaining drugs

  • Meds with high sodium content

  • Macro lines e.g. clarithromycin (risk of arrhythmia)